| Literature DB >> 35528313 |
Kandasamy Nagarajan1, Roma Ghai1, Garima Varshney1, Parul Grover1, Carlo Genovese2,3, Floriana D'Angeli4, Richa Goel1, Thota Prasad5, Muthusamy Kalaivani5, Anil Kumar Teotia5.
Abstract
Antibiotic resistance represents one of the biggest challenges, and there is an urgent need for plant-based antimicrobial agents that enable managing this crisis effectively. In this work, we aimed to investigate the antibacterial activity of Astragalus candolleanus (A. candolleanus) hydromethanolic root extract against Gram-positive (Bacillus subtilis and Staphylococcus aureus) and Gram-negative (Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Kocuria rhizophila) strains by the cup-plate method. The root was powdered and extracted with 70% methanol by cold maceration for 5 days. Preliminary phytochemical screening was performed with different solvents in the order of increasing polarity. Pure compounds were isolated by column chromatography and were characterized through liquid chromatography-mass spectrometry. Targeted predictions of the isolated compounds were also studied using Swiss Target prediction software and prediction of activity spectra for substances. The extract showed a broad zone of inhibition against pathogenic bacteria. Four pure compounds were isolated, of which a novel terpenoid compound has been identified as stemmadenine along with scillirosidin, cephalotaxine, and myxoxanthophyll. The structures of the isolated phytoconstituents were elucidated by spectral analysis. The four pure components isolated from the roots of A. candolleanus are suggested to be effective against tested pathogens. Overall results of drug design suggest that myxoxanthophyll is a promising bioactive compound endowed with antibacterial activity.Entities:
Year: 2022 PMID: 35528313 PMCID: PMC9072053 DOI: 10.1155/2022/4584799
Source DB: PubMed Journal: Int J Microbiol
Phytochemical screening for the presence of active constituents in roots of A. candolleanus.
| Solvent | Alkaloids | Glycosides | Terpenoids | Flavonoids | Saponins | Carbohydrates | Proteins | Lipids | Volatile oils | Steroids | Phenols and tannins | Gums and mucilage |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMSO | − | − | − | − | − | − | − | + | + | − | − | − |
|
| − | − | − | − | − | − | − | − | + | − | − | − |
| Petroleum ether | − | − | − | − | − | − | − | − | + | − | − | − |
| Chloroform | − | + | − | + | − | − | − | − | + | − | − | − |
| Methylene chloride | − | + | − | − | − | − | − | − | − | − | − | + |
| Acetone | − | − | − | − | − | − | − | − | + | − | − | + |
| Ethyl acetate | + | − | − | − | − | − | − | + | + | − | − | + |
| Methanol | + | − | − | − | − | − | − | + | + | − | − | + |
| Ethanol | + | − | − | − | − | − | − | + | + | − | − | + |
| Water | − | − | − | − | − | − | − | + | + | − | − | + |
| Methanol : water (7 : 3) | − | + | + | − | − | − | − | + | + | − | − | + |
| Butanol : acetic acid : water (4 : 1 : 5) | − | + | − | − | − | − | − | + | + | − | − | + |
+: presence; −: absence.
Antibacterial activity of A. candolleanus root extract and standard gentamycin (diameter inhibition zone expressed in mm).
| Bacterial strains | DMSO |
| Gentamycin ( | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 5 | 10 | 20 | 40 | 80 | 5 | 10 | 20 | 40 | ||
|
| 0 | 21.2 | 22.7 | 23.5 | 24.2 | 25.4 | 11.6 | 12.6 | 13.2 | 14.8 |
|
| 0 | 19.7 | 21.8 | — | — | — | 12.6 | 12.9 | 16.7 | 21.5 |
|
| 0 | 23.2 | 25.5 | — | — | — | 12.8 | 13.2 | 13.8 | 15.7 |
|
| 0 | 38.7 | 41.6 | — | — | — | 12.3 | 13.4 | 15.9 | 17.3 |
|
| 0 | 26.3 | 28.6 | 29.7 | 30.4 | 32.7 | 12.4 | 14.4 | 15.2 | 15.8 |
|
| 0 | 37.5 | 41.2 | — | — | — | 18.9 | 19.8 | 21.9 | 22.4 |
|
| 0 | 22.0 | 24.6 | — | — | — | 13.8 | 15.5 | 17.3 | 19.5 |
—: overlapping of zones.
Figure 1Representative image of the antibacterial effect of A. candolleanus extract against some tested bacterial strains.
FTIR analysis of hydro-methanolic A. candolleanus root extract.
| S. no. | Expected wave number (cm−1) | Observed wave number | Characteristic functional group | Compound type |
|---|---|---|---|---|
| 1 | 2850–2970 | 1434.14 | C-H | Alkane |
| 2 | 1050–1300 | 1067.65 | C-O | Alcohol, ether, carboxylic acid, esters |
| 3 | 1500–1570 | 1316.47 | NO2 | Nitro |
| 4 | 1610–1680 | 1628.95 | C=C | Alkenes |
| 5 | 1690–1760 | 1736.97 | C=O | Aldehyde, ketones, carboxylic acids, esters |
| 6 | 3200–3600 | 3240.55 | O-H | Phenols, hydrogen- bonded alcohols |
| 7 | 3500–3650 | 3515.42 | O-H | Monomeric carboxylic acids |
Figure 2FTIR spectrum of Astragalus candolleanus root extract.
Figure 3Mass spectral analysis of Astragalus candolleanus root extract by LC-MS-MS.
Figure 4Structure of isolated compounds: (i) stemmadenine, (ii) cephalotoxin, (iii), scillirosidin, (iv) and myxoxanthophyll.
Mass spectral interpretation of peak 1 from LC-MS-MS done on A. candolleanus root extract.
| S. no | Mass | Ion | Product ion and composition of neutral particle lost | Substructure or compound type | Specific |
|---|---|---|---|---|---|
| 1. | 1 | − | [M − 1]− | Fragmented ion as base peak (hydride transfer peak occurs moderately basic and acidic compounds) | 457.19 |
Mass spectral interpretation of peak 3 from LC-MS-MS done on A. candolleanus root extract.
| S. no | Mass | Ion | Product ion and composition of neutral particle lost | Substructure or compound type | Specific |
|---|---|---|---|---|---|
| 1. | 1 | − | [M − 1]− | Fragmented ion as peak | 314.15 |
| 2. | 2 | − | [M − 2]− | − | 313.15 |
Mass spectral interpretation of peak 4 from LC-MS-MS done on A. candolleanus root extract.
| S.No | Mass | Ion | Product ion and composition of neutral particle lost | Substructure or compound type | Specific |
|---|---|---|---|---|---|
| 1. | 1 | M+ | [M − 1]− | Molecular ion fragmented ion as base peak | 354.14 |
| 2. | 23 | Na+ | [M − 23]− | Organic Na + salts | 353.14 |
| 3. | 41 | C3H5+ | [M − 41]+ | Alicyclics (especially poly alicyclics) alkenes | 331.16 |
| CH3CN+ | 2-Methyl-N-aromatics-N-methyl anilines | 313.15 |
Mass spectral interpretation of peak 5 from LC-MS-MS done on A. candolleanus root extract.
| S.No | Mass | Ion | Product ion and composition of neutral particle lost | Substructure or compound type | Specific |
|---|---|---|---|---|---|
| 1. | — | M+ | — | Molecular ion | 747.40 |
| 2. | 1 | — | [M + 1]+ | Proton transfer ion | 748.411 |
Figure 5Mass spectra of peak 1.
Figure 6Mass spectra of peak 3.
Figure 7Mass spectra of peak 4.
Figure 8Mass spectra of peak 5.
Swiss Target Prediction for the bioactive isolate.
| S. no. | Name of the compound | Target | Common name | UNIPROT ID | CHEMBL ID | Target class | Probability | Known active (3D/2D) |
|---|---|---|---|---|---|---|---|---|
| 1 | Scillirosidin | MAP | MAPK14 | Q16539 | CHEMBL260 | Kinase | 0.100634432184 | 158/0 |
| MAP Kinase | MAPK11 | Q15759 | CHEMBL 3961 | Kinase | 0.100634432184 | 176/0 | ||
| Interleukin-8 receptor B | CXCR2 | P25025 | CHEMBL 2434 | Family AG-protein coupled receptor | 0.100634432184 | 108/0 | ||
| 2 | Cephalotaxine | Inhibitor of apoptosis protein 3 | X1AP | P98170 | CHEMBL 4198 | Other cytosolic proteins | 0.0 | 16/0 |
| 3 | Stemmadenine | Inhibitor of apoptosis protein 3 | X1AP | P98170 | CHEMBL 4198 | Other cytosolic proteins | 0.109339753231 | 116/0 |
| 4 | Myxoxanthophyll | Interleukin-2 (IL-2) | IL-2 | P60568 | CHEMBL5880 | Secreted protein | 0.428381527054 | 0/1 |
| Interleukin-8 receptor | CXCR1 | P25024 | CHEMBL4029 | Family AG-protein coupled receptor | 0.0 | 0/2 |
Probability for the query molecule assumed as bioactive to have this protein as target.
PASS online predictivity score for bioactive compounds.
| S. no | Name of isolated phytoconstituent | PASS (activity)/(inactivity) prediction score Pa | Key mechanism of bioactivity | |
|---|---|---|---|---|
| 1 | Scillirosidin (moderately active) | 0.43200.33900. | 0.0590.0460. | Apoptosis agonist |
| 2 | Cephalotaxine (high activity) | 0.92300.19100.0660 | 0.0600.0040.058 | Antioxidants |
| 3 | Stemmadenine (moderately active) | 0.37900.34200.35500.0970 | 0.830.621.190.87 | Apoptosis agonistMAP3K5 inhibitorAnti-inflammatoryMAP kinase inhibitor |
| 4 | Myxoxanthophyll (high activity) | 0.86600.82700.71700.21900.1230 | 0.050.0030.0140.0160.031 | Apoptosis agonist |
Pa > 0.7: highly active; Pa > 0.3: moderately active; Pa > 0.1: less active.